These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 1834287

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M, Beuzeboc P, Mauriac L, Barbet N, Frenay M, Monnier A, Pion JM, Switsers O, Misset JL, Assadourian S, Bessa E.
    Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Role and use of biphosphonates in the treatment of metastatic breast cancer].
    Caulin F.
    Pathol Biol (Paris); 1990 Oct; 38(8):862-3. PubMed ID: 2148817
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ, Mancini I.
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of skeletal disease in breast cancer with clodronate.
    Paterson AH, Ernst DS, Powles TJ, Ashley S, McCloskey EV, Kanis JA.
    Bone; 1991 Jul; 12 Suppl 1():S25-30. PubMed ID: 1720012
    [Abstract] [Full Text] [Related]

  • 14. [Clodronate in treatment of tumor osteopathy. Evaluation in tumor patients with bone metastases or hypercalcemia].
    Voigtmann R, Kirstein A.
    Fortschr Med; 1994 Feb 10; 112(4):43-6. PubMed ID: 7512066
    [Abstract] [Full Text] [Related]

  • 15. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.
    Brown JE, McCloskey EV, Dewar JA, Body JJ, Cameron DA, Harnett AN, Ruutu M, Purohit OP, Tähtelä R, Coleman RE.
    Calcif Tissue Int; 2007 Nov 10; 81(5):341-51. PubMed ID: 17874331
    [Abstract] [Full Text] [Related]

  • 16. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE, Siris ES, Jacobs TP.
    Bone; 1987 Nov 10; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [Abstract] [Full Text] [Related]

  • 17. [Clodronate and radiotherapy for the treatment of osteolysis caused by metastasis of breast carcinoma and non-small cell lung carcinoma. A retrospective study].
    Caristi N, Russi EG, Adamo V, Altavilla G, d'Aquino A, Delia P, Di Carlo M, Maisano R, Romeo F, Salvi L.
    G Ital Oncol; 1990 Nov 10; 10(4):129-32. PubMed ID: 1965506
    [Abstract] [Full Text] [Related]

  • 18. Clodronate in the prevention and treatment of skeletal metastasis.
    Gulley J, Dahut WL.
    Expert Rev Anticancer Ther; 2005 Apr 10; 5(2):221-30. PubMed ID: 15877520
    [Abstract] [Full Text] [Related]

  • 19. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ, Dranitsaris G, Ooi WS, Yogendran G, Sukovic T, Wong BY, Verma S, Pritchard KI, Trudeau M, Cole DE.
    J Clin Oncol; 2006 Oct 20; 24(30):4895-900. PubMed ID: 17001071
    [Abstract] [Full Text] [Related]

  • 20. Clinical trials in metastatic breast cancer to bone: past--present--future.
    Body JJ.
    Can J Oncol; 1995 Dec 20; 5 Suppl 1():16-27. PubMed ID: 8853520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.